Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2583073

CCCCCCCCCCCCCCOCCCCCCCCCCCCCC.N.N

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.67
HTT P42858 2/20 0.67
MEN1 O00255 1/20 0.67
KMT2A Q03164 1/20 0.67
MAPT P10636 1/20 0.67
CES2 O00748 2/20 0.54
TSHR P16473 2/20 0.53
ALDH1A1 P00352 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
USP2 O75604 1/20 0.50
CES1 P23141 1/20 0.48
LPAR3 Q9UBY5 3/20 0.44
LPAR1 Q92633 2/20 0.44
LPAR2 Q9HBW0 2/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL722492 1.00 THRB (0.67) THRBHTTMEN1KMT2AMAPT
Ammonia Solution, Strong SCHEMBL2587274 1.00 THRB (0.67) THRBHTTMEN1KMT2AMAPT
Ammonia Solution, Strong SCHEMBL715799 1.00 THRB (0.67) THRBHTTMEN1KMT2AMAPT
Ammonia Solution, Strong SCHEMBL4438557 1.00 THRB (0.67) THRBHTTMEN1KMT2AMAPT
Ammonia Solution, Strong SCHEMBL2587267 1.00 THRB (0.67) THRBHTTMEN1KMT2AMAPT
Ammonia Solution, Strong SCHEMBL715250 1.00 THRB (0.67) THRBHTTMEN1KMT2AMAPT
Ammonia Solution, Strong SCHEMBL6009607 1.00 THRB (0.67) THRBHTTMEN1KMT2AMAPT
Ammonia Solution, Strong SCHEMBL715486 1.00 THRB (0.67) THRBHTTMEN1KMT2AMAPT
Ammonia Solution, Strong SCHEMBL714199 1.00 THRB (0.67) THRBHTTMEN1KMT2AMAPT
Ammonia Solution, Strong SCHEMBL27640240 1.00 THRB (0.67) THRBHTTMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8049039-B2 Process for preparation of alkoxylated alkylamines/alkyl ether amines with peaked distribution AKZO NOBEL N.V. (NL) 2011-11-01 US claimed
US-20090209788-A1 PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION AKZO NOBEL N.V. (NL) 2009-08-20 US claimed
CN-101479232-A Process for preparation of alkoxylated alkylamines / alkyl ether amines with peaked distribution AKZO NOBEL NV (NL) 2009-07-08 CN claimed
EP-2032523-A1 PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION Akzo Nobel N.V. (NL) 2009-03-11 EP claimed
WO-2007147866-A1 PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION AKZO NOBEL N.V. (NL) 2007-12-27 WO claimed
EP-1793667-A1 ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION Akzo Nobel N.V. (NL) 2007-06-13 EP claimed
WO-2006034459-A1 ALKOXYLATED ALKYLAMINES / ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION AKZO NOBEL N.V. (NL) 2006-03-30 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209788-A1 PROCESS FOR PREPARATION OF ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION ALKBH3, ALKBH2, ALKBH5 THRB 4617/4885HTT 1612/4885MEN1 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.